Bausch Health Companies Stock Price To Sales
| BVF Stock | EUR 7.63 0.20 2.69% |
Bausch Health Companies fundamentals help investors to digest information that contributes to Bausch Health's financial success or failures. It also enables traders to predict the movement of Bausch Stock. The fundamental analysis module provides a way to measure Bausch Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bausch Health stock.
Bausch |
Bausch Health Companies Company Price To Sales Analysis
Bausch Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Bausch Health Price To Sales | 0.32 X |
Most of Bausch Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bausch Health Companies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Bausch Health Companies has a Price To Sales of 0.3211 times. This is 98.5% lower than that of the Healthcare sector and 99.07% lower than that of the Drug Manufacturers - Specialty & Generic industry. The price to sales for all Germany stocks is 97.19% higher than that of the company.
Bausch Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bausch Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bausch Health could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics of similar companies.Bausch Health is currently under evaluation in price to sales category among its peers.
Bausch Fundamentals
| Return On Equity | -1.88 | |||
| Return On Asset | 0.0338 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 22.26 B | |||
| Shares Outstanding | 361.87 M | |||
| Shares Owned By Insiders | 3.27 % | |||
| Shares Owned By Institutions | 81.80 % | |||
| Price To Earning | 3.37 X | |||
| Price To Book | 18.34 X | |||
| Price To Sales | 0.32 X | |||
| Revenue | 8.12 B | |||
| Gross Profit | 5.76 B | |||
| EBITDA | 2.55 B | |||
| Net Income | (225 M) | |||
| Cash And Equivalents | 782 M | |||
| Cash Per Share | 2.22 X | |||
| Total Debt | 22.65 B | |||
| Debt To Equity | 880.60 % | |||
| Current Ratio | 1.09 X | |||
| Book Value Per Share | (1.91) X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 0.71 X | |||
| Target Price | 35.82 | |||
| Number Of Employees | 19.9 K | |||
| Beta | 1.06 | |||
| Market Capitalization | 3.11 B | |||
| Total Asset | 29.2 B | |||
| Net Asset | 29.2 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Bausch Stock
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.